The top executive at Pfizer, a leading producer of COVID-19 vaccines, has tested positive for the virus and says he is experiencing very mild symptoms.
Chairman and CEO Albert Bourla said Monday that he started taking Pfizer's Paxlovid pill treatment and is isolating while he recovers.
More than 128 million people in the United States have become fully vaccinated with Pfizer's two-shot vaccine since it entered the market more than a year ago and almost 61 million have received an initial booster shot, according to the Centers for Disease Control and Prevention. Pfizer and another vaccine maker, Moderna, are updating their shots to provide protection against newer versions of the virus for a fall booster campaign.
United States Latest News, United States Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Pfizer CEO tests positive for COVID-19Bourla said he has received four shots of Comirnaty, the COVID-19 vaccine developed by Pfizer and BioNTech.
Read more »
Pfizer CEO Albert Bourla tests positive for CovidBourla, 60, said he had started a course of the company’s oral Covid-19 antiviral treatment, Paxlovid, and was isolating and following all public health precautions.
Read more »
A lightspeed approach to pandemic drug development - Nature MedicinePfizer developed both a vaccine (with BioNTech_Group) and an antiviral against COVID-19 by streamlining decisions and running steps in parallel - a lightspeed approach that can be applied to other diseases. World View from Annaliesa Anderson pfizer
Read more »
With updated COVID vaccines coming soon, should people wait on getting boosted?Both Pfizer and Moderna are working on updated vaccines that will not only be effective against the original strain of COVID-19 but also the most recent variants like Omicron BA.1.
Read more »
Jill Biden tests positive for COVID-19, has ‘mild’ symptomsFirst lady Jill Biden tested positive for COVID-19 and was experiencing “mild symptoms,” the White House announced Tuesday.
Read more »